Gilder Gagnon Howe & Co’s LivaNova LIVN Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio LIVN Stock Details LIVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,344	Closed	-$167K	–	276
2018 Q3	$167K	Buy	+1,344	New	+$159K	﹤0.01%	264

Other funds holding LIVN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Gilder Gagnon Howe & Co's LIVN Position: Q4 2018 in Review

Gilder Gagnon Howe & Co sold out of LivaNova (LIVN) in Q4 2018, closing a stake of 1,344 shares — an estimated $167K sold.

Gilder Gagnon Howe & Co first reported a position in LIVN in Q3 2018 and held it in 1 quarter. The position peaked at $167K in Q3 2018. 251 funds tracked by Wall St. Rank hold LIVN as of Q4 2018.

Gilder Gagnon Howe & Co reported no remaining LivaNova position as of Q4 2018 after selling out during the quarter.
Gilder Gagnon Howe & Co sold 1,344 LivaNova shares in Q4 2018, an estimated $167K.
Gilder Gagnon Howe & Co first reported a position in LivaNova in Q3 2018 and held it in 1 quarter.
Gilder Gagnon Howe & Co's LivaNova position peaked at $167K in Q3 2018.
251 funds tracked by Wall St. Rank held LivaNova as of Q4 2018.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2018, filed 14 Feb 2019.